Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of platycodin D to preparation of medicine for preventing and treating porcine reproductive and respiratory syndrome

A technology for respiratory syndrome and platycodon saponin, which is applied in drug combinations, respiratory diseases, and pharmaceutical formulations. It can solve problems that have not been disclosed, and its effects have not been reported, and achieve good anti-PRRSV activity.

Inactive Publication Date: 2016-07-20
SOUTH CHINA AGRI UNIV +1
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] There is no report on the anti-porcine reproductive and respiratory disease virus effect of bellflower saponins, and no related patent publications

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of platycodin D to preparation of medicine for preventing and treating porcine reproductive and respiratory syndrome
  • Application of platycodin D to preparation of medicine for preventing and treating porcine reproductive and respiratory syndrome
  • Application of platycodin D to preparation of medicine for preventing and treating porcine reproductive and respiratory syndrome

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Embodiment 1: the protective effect of the medicine of the present invention to the Marc-145 cell that infects PRRSV

[0031] Collect Marc-145 cells in the logarithmic growth phase, and add 0.1 mL (about 3×10 4cells / well), discard the culture medium after the cell monolayer grows to 80% confluence, wash twice with PBS, then add 0.2MOI (multiplicity of virus infection) of PRRSV virus, 100 μL / well, 37°C Incubate for 2 hours, discard the virus supernatant, wash twice with PBS, add 5 μM and 15 μM platycodon saponin D, 100 μL / well, respectively. A normal control group (no test drug, no PRRSV) and a virus control group (no test drug) were set up in the experiment at the same time, and three parallels were set for each test concentration. The cells continued to be cultured for 48 hours, and then the culture was terminated. Discard the supernatant, wash with PBS 3 times, add 500 μl of paraformaldehyde with a mass concentration of 4% to each well for fixation for 10 min; wash ...

Embodiment 2

[0032] Implementation 2: The inhibitory effect of the medicine of the present invention on the proliferation of PRRSV on Marc-145 cells at the mRNA level

[0033] Marc-145 cells in logarithmic growth phase were collected, and 2.0 mL (1×106 cells / well) was added to each well of a six-well plate. After the cell monolayer grew to 80% confluence, the medium was discarded, and PBS was washed twice. Then add 0.2MOI of PRRSV virus, 700μL / well, incubate at 37°C for 2h, discard the virus supernatant, wash twice with PBS, add 5μM and 15μM Platycodon saponin D, 2mL / well, respectively, recorded as PD5μM group and PD15μM group. A normal control group (no test drug, no PRRSV) and a virus control group (no test drug) were set up in the experiment at the same time, and three parallels were set for each test concentration. The cells continued to be cultured at 37°C, and the culture was terminated 48 hours after infection. After observing the lesions, the cell plate was repeatedly frozen and ...

Embodiment 3

[0041] Embodiment 3: The medicine of the present invention inhibits the synthesis of N protein of PRRSV

[0042] Experimental grouping, cell inoculation, virus infection and dosing were the same as in Example 2. Cells were cultured at 37°C until 48 hours after infection, and the culture was terminated. Sample protein extraction and Western blot analysis of N protein were carried out.

[0043] Sample protein extraction:

[0044] Discard the medium after the cells have been cultured for 48 hours, wash twice with pre-cooled PBS, discard the PBS solution, add an appropriate amount of cell lysate according to the number of cells, and keep in an ice bath for 5-10 minutes. The lysate, after the lysis is completed, transfer the liquid to a new EP tube, centrifuge at 4°C (14000rpm, 5min); absorb the supernatant and transfer it to a pre-cooled centrifuge tube, which is the extracted total cell protein. The extracted total cell protein aliquots were stored at -80°C until used for Wester...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of platycodin D to the preparation of medicine for resisting PRRSV (porcine reproductive and respiratory syndrome virus) and preventing and treating porcine reproductive and respiratory syndrome. The platycodin D is separated from the roots of platycodon grandiflorum. Methods such as immunofluorescence microscopic analysis, RT-PCR and Western blot prove that the platycodin D has good PRRSV resisting activity on Marc-145 cells and can hopefully become medicine for preventing and treating the porcine reproductive and respiratory syndrome. The fact that the platycodin D has the PRRSV resisting activity is discovered for the first time, and the platycodin D is evident in curative effect on pigs infected with PRRSV.

Description

technical field [0001] The invention belongs to the technical field of veterinary medicines, and more specifically relates to the use of platycodon saponin D, a component extracted from platycodon grandiflorum, in the preparation of medicines for preventing and treating porcine reproductive and respiratory syndrome. Background technique [0002] Porcine reproductive and respiratory syndrome (PRRS) is an acute, contact and highly contagious disease of pigs caused by porcine reproductive and respiratory syndrome virus (PRRSV). Its main clinical feature is to cause reproductive disorders such as abortion, premature birth, stillbirth, weak fetus and mummified fetus in pregnant sows, and respiratory symptoms in piglets and fattening pigs. Because the clinically affected pigs have blue ears, the disease is commonly known as "pig blue ear disease". PRRS first broke out in North America in 1987, and became popular in mainland China in 1996. In 2006, the highly pathogenic PRRS first...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/704A61P31/14A61P11/00A61P15/00
CPCA61K31/704A61K36/34
Inventor 陈建新周红霞邱电曾振灵郭霄峰田鸽张明昕
Owner SOUTH CHINA AGRI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com